Summary: Researchers report promising results treating post-traumatic stress disorder (PTSD) in military veterans by combining noninvasive brain stimulation with immersive virtual reality (VR) exposure therapy. In a double-blind clinical trial, veterans who received low-current transcranial direct current stimulation (tDCS) targeted to the ventromedial prefrontal cortex during standardized warzone VR sessions showed greater and faster reductions in PTSD symptoms than those who received a sham stimulation.
This integrated approach—leveraging neuroscience and psychotherapy—improved symptom severity and accelerated physiological and psychological adjustment to trauma-related cues. The findings, published in JAMA Psychiatry, highlight the potential of combining tDCS with VR exposure to enhance outcomes for people with chronic PTSD, particularly military veterans who often struggle with traditional treatments.
Key Facts:
- Innovative combined therapy: The trial paired transcranial direct current stimulation (tDCS) with immersive virtual reality exposure to address warzone-related PTSD symptoms in veterans.
- Improved efficacy and speed: Participants receiving active tDCS reported larger reductions in self-reported PTSD symptoms at one month and showed faster psychophysiological habituation than the sham group.
- Practical benefits: VR-based exposure can be easier for patients to tolerate than repeated personal recounting of trauma, and adding tDCS appears to accelerate therapeutic gains that normally require weeks of prolonged exposure therapy.
Source: Brown University
Combining brain stimulation with virtual reality exposure shows promise for veterans with PTSD.
In a randomized, double-blind clinical trial at the Providence Veterans Affairs Medical Center, researchers tested whether active transcranial direct current stimulation (tDCS) plus standardized warzone virtual reality (VR) exposure could reduce PTSD symptoms more effectively than VR with sham tDCS. The trial enrolled 54 U.S. military veterans with chronic, warzone-related PTSD.
Noah Philip, a professor of psychiatry and human behavior at Brown University’s Warren Alpert Medical School and lead investigator at the Providence V.A. Center for Neurorestoration and Neurotechnology, said the combination of psychotherapy and noninvasive neuromodulation offers a new path forward for patients who have limited benefit from or difficulty tolerating existing PTSD treatments.
Traditional options—trauma-focused exposure therapy and medication—often present challenges for veterans. Medications can produce unwanted side effects, and exposure therapy requires patients to repeatedly recount traumatic memories, a process that many find intolerable; dropout rates for conventional exposure therapy can reach as high as 50% in some settings. VR exposure provides immersive but generalized scenarios that recreate the sensory context of warzone experiences without requiring patients to repeatedly describe their personal traumas, which may improve tolerability and retention.
The tDCS procedure delivers a constant, low-intensity electrical current to the scalp to modestly increase neural excitability in targeted brain regions. In this study, researchers targeted the ventromedial prefrontal cortex, a brain area involved in regulating fear and safety learning. The theoretical rationale is that enhancing top-down control of the amygdala and related circuits can improve safety learning and reduce the conditioned fear responses that underlie PTSD symptoms.
A treatment that accelerates results
Participants were randomized to active tDCS (2 milliamps anodal stimulation) or sham tDCS during six 25-minute standardized warzone VR sessions delivered over two to three weeks. Both groups experienced meaningful symptom reductions attributed to the VR exposure itself, but those in the active tDCS group reported significantly greater improvement in self-reported PTSD symptoms at the one-month assessment (Cohen’s d ≈ 0.82).
Active tDCS also accelerated psychophysiological habituation across VR sessions compared with sham stimulation, indicating faster reduction in physiological reactivity to trauma-related cues. Importantly, the study found that symptom improvement continued after treatment ended, with the largest effects observed around one month post-treatment—suggesting ongoing consolidation of therapeutic gains.
The VR scenarios used in this trial included generalized trauma-inducing elements rather than recreating any single participant’s personal events, which helped participants engage with exposure without repeatedly narrating intimate traumatic memories. Investigators note that the combination of tDCS and VR produced effects in two weeks similar to improvements that might otherwise require many weeks of standard prolonged exposure therapy.
Researchers are continuing to analyze neural and clinical data to better understand the mechanisms behind these changes and to determine whether benefits persist long-term. Future studies will examine larger samples, extended follow-up periods, and the potential advantages of booster or repeat sessions.
Other Brown University researchers contributing to the study included Amanda R. Arulpragasam, M. Tracie Shea and Benjamin D. Greenberg. The trial received funding from the U.S. Department of Veterans Affairs (grants I01 RX002450 and I50 RX002864).
About this PTSD and neurotech research news
Author: Corrie Pikul
Source: Brown University
Contact: Corrie Pikul – Brown University
Image: The image is credited to Neuroscience News
Original Research: Open access. “Virtual Reality and Transcranial Direct Current Stimulation for Posttraumatic Stress Disorder: A Randomized Clinical Trial” by Noah Philip et al., published in JAMA Psychiatry.
Abstract
Virtual Reality and Transcranial Direct Current Stimulation for Posttraumatic Stress Disorder: A Randomized Clinical Trial
Importance
Posttraumatic stress disorder (PTSD) is a prevalent psychiatric condition that can be especially difficult to treat in military veterans. Noninvasive brain stimulation techniques, paired with evidence-based psychotherapies, offer potential novel approaches to reduce PTSD symptoms.
Objective
To determine whether active transcranial direct current stimulation plus virtual reality exposure is superior to sham tDCS plus VR for treating warzone-related PTSD.
Design, Setting, and Participants
This double-blind randomized clinical trial enrolled U.S. military veterans with chronic PTSD and warzone-related exposure from April 2018 to May 2023 at a Department of Veterans Affairs medical center. The study included 1- and 3-month follow-up visits and analyzed data collected through September 2023.
Intervention
Participants were randomized to receive 2-mA anodal tDCS targeted to the ventromedial prefrontal cortex or sham tDCS during six 25-minute sessions of standardized warzone VR exposure over two to three weeks.
Main Outcomes and Measures
Primary outcomes included self-reported PTSD symptom severity (PCL-5) and quality of life. Secondary outcomes assessed psychophysiological arousal, clinician-rated PTSD, depressive symptoms, and social/occupational functioning.
Results
Fifty-four participants (mean age 45.7 years; 94% male) completed the trial (26 active tDCS, 28 sham). The active tDCS group reported greater reductions in self-reported PTSD symptoms at one month (statistically significant) and demonstrated faster psychophysiological habituation to VR events. Adverse effects were consistent with the known safety profiles of the interventions.
Conclusions and Relevance
Combining tDCS with VR exposure may be a promising strategy to accelerate and enhance PTSD symptom reduction. These early clinical results support further investigation of integrated neurotechnology and psychotherapy approaches for PTSD.
Trial Registration
ClinicalTrials.gov Identifier: NCT03372460